When Will Wegovy Be Available on the NHS?

Wegovy received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) as a prescription-only medicine for weight management in adults. NHS England subsequently confirmed it would be introduced in a structured, phased way — starting with specialist tier-3 weight management services before broader access. This phased approach is partly due to global supply constraints and the need to prioritise clinical pathways.

What this means in practice

Access to Wegovy through publicly funded healthcare is not uniform worldwide, and even within one country the rollout can differ by region and service. In the UK specifically, NHS availability has been limited in early phases, with private prescriptions offering a separate route for those who qualify and are assessed by a registered prescriber. In Ireland and other countries, the situation is governed by each nation's own regulatory and funding bodies — there is no single answer that applies everywhere.

If you are wondering about availability in your specific country or region, your prescriber or doctor is the most reliable source of up-to-date information. They will know what is accessible through your local healthcare system and whether you meet the criteria currently in use.

The 2.4 mg maintenance dose and higher strengths

Questions about when specific dose strengths — such as the 2.4 mg maintenance dose or any future higher-strength formulations — will become more widely available are best directed to your prescriber or a registered pharmacy in your country. Supply situations change, and no single source outside of official channels will have the most current picture. For information on how Wegovy and its dose stages are generally described, the electronic Medicines Compendium (eMC) holds the official UK product information.

For related NHS access questions about tirzepatide, see our pages on when Mounjaro may become available on the NHS and Mounjaro's NHS availability timeline. You may also find our broader look at when Wegovy will be available useful for the wider international picture.

Whether you accessed Wegovy through a public health service, a private prescriber, or any other legitimate route, what matters most once you have your prescription is staying consistent and making every dose count. That is exactly what GLP Trackr is designed to help with.

The most useful starting point for Wegovy users is dose and injection logging. The app lets you record each weekly shot — the date, the dose strength, and the injection site — so you always have a clear record of where you are in your treatment. If you are working through the titration schedule your prescriber set out, having that log makes it easy to review at your next appointment and ensures nothing gets lost or forgotten.

Beyond dose tracking, the app's side-effect and symptom logging means you can note how you feel in the days after each injection and spot patterns over time. This kind of organised record is genuinely useful to bring to your prescriber — far more informative than trying to recall how things felt several weeks ago. For a broader look at cost and access considerations across GLP-1 medicines, our guide to GLP-1 medication costs covers the wider context.

GLP Trackr does not sell, supply, or source Wegovy or any other medication. For questions about obtaining a prescription or accessing the medicine in your country, please speak with your prescriber or doctor, or contact a registered pharmacy in your area.

Any decisions about your dose, your treatment schedule, or whether Wegovy is right for you should always be made with your prescriber — they know your full medical history in a way no app can.

If you are already on Wegovy and want a cleaner way to track your journey, GLP Trackr is free to get started — available on the App Store and Google Play with a 7-day free trial. Log your doses, record how you feel, and bring a clear picture of your progress to every prescriber conversation.